Pending EO 12866 Regulatory Review

RIN: 1545-BR16	Received Date: 11/14/2025
Title: Branded Prescription Drug Fee Discounts
Agency/Subagency: TREAS / IRS	Stage: Proposed Rule
Legal Deadline: None	Economically Significant: No
International Impacts: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
Pandemic Response: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No